Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FZ830
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,643
Award facts
- Contract value 100% obligated
- $14,643.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $14,643.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, was executed without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supporting Department of Defense pharmaceutical supply needs globally.
Under the PPV-G GEN V contract framework—which carries a ceiling value of $499,999,999 and extends through December 31, 2036—DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities worldwide. The contractor's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals, demonstrating the breadth of medical supply support required to sustain Department of Defense healthcare operations. DMS Pharmaceutical Group has established consistent contract performance through numerous delivery orders issued since October 2025, positioning the company as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DU26FZ830?
SPE2DU26FZ830 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DU26FZ830 worth?
The government has obligated $14,643 on SPE2DU26FZ830.
Is contract SPE2DU26FZ830 an order under another contract?
Yes. SPE2DU26FZ830 is a delivery order under SPE2DU25D9434, an indefinite delivery contract.
Was contract SPE2DU26FZ830 competed?
The extent of competition for SPE2DU26FZ830 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award